These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 23676258)
1. Seasonal dynamics of tuberculosis epidemics and implications for multidrug-resistant infection risk assessment. Lin YJ; Liao CM Epidemiol Infect; 2014 Feb; 142(2):358-70. PubMed ID: 23676258 [TBL] [Abstract][Full Text] [Related]
2. Assessing the transmission risk of multidrug-resistant Mycobacterium tuberculosis epidemics in regions of Taiwan. Liao CM; Lin YJ Int J Infect Dis; 2012 Oct; 16(10):e739-47. PubMed ID: 22818291 [TBL] [Abstract][Full Text] [Related]
3. Burden of transmitted multidrug resistance in epidemics of tuberculosis: a transmission modelling analysis. Kendall EA; Fofana MO; Dowdy DW Lancet Respir Med; 2015 Dec; 3(12):963-72. PubMed ID: 26597127 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis. Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491 [TBL] [Abstract][Full Text] [Related]
5. The risk of global epidemic replacement with drug-resistant Mycobacterium tuberculosis strains. McBryde ES; Meehan MT; Doan TN; Ragonnet R; Marais BJ; Guernier V; Trauer JM Int J Infect Dis; 2017 Mar; 56():14-20. PubMed ID: 28163165 [TBL] [Abstract][Full Text] [Related]
7. Decline in rates of acquired multidrug-resistant tuberculosis after implementation of the directly observed therapy, short course (DOTS) and DOTS-Plus programmes in Taiwan. Chien JY; Lai CC; Tan CK; Chien ST; Yu CJ; Hsueh PR J Antimicrob Chemother; 2013 Aug; 68(8):1910-6. PubMed ID: 23580558 [TBL] [Abstract][Full Text] [Related]
8. Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa. Cox HS; McDermid C; Azevedo V; Muller O; Coetzee D; Simpson J; Barnard M; Coetzee G; van Cutsem G; Goemaere E PLoS One; 2010 Nov; 5(11):e13901. PubMed ID: 21085569 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up. Schaaf HS; Gie RP; Kennedy M; Beyers N; Hesseling PB; Donald PR Pediatrics; 2002 May; 109(5):765-71. PubMed ID: 11986434 [TBL] [Abstract][Full Text] [Related]
10. TB and MDR-TB. Flanders RA Ill Dent J; 1994; 63(3):145-8. PubMed ID: 7927406 [No Abstract] [Full Text] [Related]
11. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis (MDR-TB) isolates identifies local transmission of infection in Kuwait, a country with a low incidence of TB and MDR-TB. Al-Mutairi NM; Ahmad S; Mokaddas EM Eur J Med Res; 2019 Dec; 24(1):38. PubMed ID: 31806020 [TBL] [Abstract][Full Text] [Related]
12. Infection and disease among household contacts of patients with multidrug-resistant tuberculosis. Teixeira L; Perkins MD; Johnson JL; Keller R; Palaci M; do Valle Dettoni V; Canedo Rocha LM; Debanne S; Talbot E; Dietze R Int J Tuberc Lung Dis; 2001 Apr; 5(4):321-8. PubMed ID: 11334250 [TBL] [Abstract][Full Text] [Related]
13. Strategies for halting the rise of multidrug resistant TB epidemics: assessing the effect of early case detection and isolation. Espindola AL; Varughese M; Laskowski M; Shoukat A; Heffernan JM; Moghadas SM Int Health; 2017 Mar; 9(2):80-90. PubMed ID: 28338827 [TBL] [Abstract][Full Text] [Related]
14. Epidemiology of Drug-Resistant Tuberculosis. Dean AS; Cox H; Zignol M Adv Exp Med Biol; 2017; 1019():209-220. PubMed ID: 29116637 [TBL] [Abstract][Full Text] [Related]
15. Tuberculosis and air travel: WHO guidance in the era of drug-resistant TB. Martinez L; Blanc L; Nunn P; Raviglione M Travel Med Infect Dis; 2008 Jul; 6(4):177-81. PubMed ID: 18571104 [TBL] [Abstract][Full Text] [Related]
16. Multidrug-resistant tuberculosis and risk factors associated with its development: a retrospective study. Elmi OS; Hasan H; Abdullah S; Mat Jeab MZ; Bin Alwi Z; Naing NN J Infect Dev Ctries; 2015 Oct; 9(10):1076-85. PubMed ID: 26517482 [TBL] [Abstract][Full Text] [Related]
17. The importance of implementation strategy in scaling up Xpert MTB/RIF for diagnosis of tuberculosis in the Indian health-care system: a transmission model. Salje H; Andrews JR; Deo S; Satyanarayana S; Sun AY; Pai M; Dowdy DW PLoS Med; 2014 Jul; 11(7):e1001674. PubMed ID: 25025235 [TBL] [Abstract][Full Text] [Related]
18. High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from? Ragonnet R; Trauer JM; Denholm JT; Marais BJ; McBryde ES BMC Infect Dis; 2017 Jan; 17(1):36. PubMed ID: 28061832 [TBL] [Abstract][Full Text] [Related]
19. Two simultaneous outbreaks of multidrug-resistant tuberculosis--Federated States of Micronesia, 2007-2009. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2009 Mar; 58(10):253-6. PubMed ID: 19300407 [TBL] [Abstract][Full Text] [Related]
20. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan. van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]